Bimzelx 160 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26F1T97
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $154,028
Award facts
- Contract value 100% obligated
- $154,028.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $154,028.03 firm fixed-price delivery order to AmerSourceBergen Drug Corp for BIMZELX 160 mg/mL auto-injectors on January 9, 2026, with completion targeted for January 12, 2026. The award was made on a competitive, non-set-aside basis, with performance at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerSourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through December 31, 2031. This prime IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities.
AmerSourceBergen Drug Corp functions as a major pharmaceutical distributor within the federal medical procurement ecosystem and has demonstrated substantial capability to fulfill DLA requirements through open competition. The company consistently delivers specialized pharmaceutical products across multiple therapeutic domains to support military treatment facilities and federal healthcare systems. This particular order for BIMZELX, a biopharmaceutical product, reflects the company's role in supplying specialty medications to the Department of Defense's medical supply chain and underscores its position as a critical vendor for federal pharmaceutical procurement needs.
Quick answers
Who was awarded contract SPE2DR26F1T97?
SPE2DR26F1T97 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F1T97 worth?
The government has obligated $154,028 on SPE2DR26F1T97.
Is contract SPE2DR26F1T97 an order under another contract?
Yes. SPE2DR26F1T97 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1T97 competed?
The extent of competition for SPE2DR26F1T97 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award